Approval · Notice of Compliance 1519 · 2000
CARDIOLITE: Notice of Compliance 1519
Issued December 13, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1519
- Date
- December 13, 2000
- Company
- Dupont Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate manufacturing site
- Therapeutic class
- Diagnostic radiopharmaceutical for myocardial infarction
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CARDIOLITE | Not yet assigned | — |
Medicinal ingredients
- TETRAKIS [CU(MIB)4]BF4 1 MG per VIAL